Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: Open label study

Table 4 Duration of fasting, duration of hospitalization and reduction in the ulcer score: Comparison between the rebamipide and conventional therapy groups

	Conventional group (n = 9)	Rebamipide group (n = 6)	Statistical significance
Duration of fasting (d)	7.9 ± 4.1	2.7 ± 1.8	P = 0.0121
Duration of hospitalization (d)	17.9 ± 6.8	9.2 ± 1.5	P = 0.0092
Degree of ulcer healing1 (points)	2.8 ± 0.5 (n = 5)	3.5 ± 0.5	P = 0.0797
WBC decrease2 (× 103/&mgr;L)	8.6 ± 5.7	12.0 ± 5.6	P = 0.3360

Values are the mean ± SD.

¹The ulcer lesion was scored according to the Sakita-Miwa classification of the stage of gastric ulcer, then the difference between the baseline score (at the time of diagnosis) and at the time of the follow-up colonoscopy was divided by the number of days between the baseline and the follow-up examination, to correct the results to the value on d 7 (A1: 6 points, A2: 5 points, H1: 4 points, H2: 3 points, S1: 2 points, S2: 1 point).

²Difference in value between that measured at admission and that measured at the time of the follow-up was divided by the number of days between the two examinations to correct the results to the value on d 7.